Publications by authors named "Ake Borg"

Claim this Profile
M
Molecular profiling of the Basal-like intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.
Lennart Hohmann, Deborah F Nacer, Mattias Aine, Yasin Memari, Daniella Black, Åke Borg

Genome Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis.
Daniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, Lucia Chmelova, Marko Cubric, Åke Borg

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer.
Anders Kvist, Anders Kämpe, Therese Törngren, Bianca Tesi, Panagiotis Baliakas, Åke Borg

Breast Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characteristics Related to Histology-Based Immune Features in Breast Cancer.
Yoon Jin Cha, Constandina E O'Connell, Benjamin C Calhoun, Brooke M Felsheim, Aranzazu Fernandez-Martinez, Åke Borg

Mod Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.
Lennart Hohmann, Kristin Sigurjonsdottir, Ana Bosch Campos, Deborah F Nacer, Srinivas Veerla, Nicklas Nordborg, Åke Borg

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA methylation landscape of primary triple-negative breast cancer.
Mattias Aine, Deborah F Nacer, Elsa Arbajian, Srinivas Veerla, Anna Karlsson, Åke Borg

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 frameshift variants leading to extended incorrect protein C termini.
Thales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, John Michael O Ranola, Jamie Weyandt, Åke Borg

HGG Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 frameshift variants leading to extended incorrect protein C termini.
Thales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, John Michael O Ranola, Jamie Weyandt, Åke Borg

HGG Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Åke Borg

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study.
Kamil Demircan, Ylva Bengtsson, Thilo Samson Chillon, Johan Vallon-Christersson, Qian Sun, Åke Borg

J Transl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Anna Öfverholm, Therese Törngren, Anna Rosén, Brita Arver, Zakaria Einbeigi, Åke Borg

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study.
Ylva Bengtsson, Kamil Demircan, Johan Vallon-Christersson, Martin Malmberg, Lao H Saal, Åke Borg

Redox Biol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity-associated changes in molecular biology of primary breast cancer.
Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens, Samuel Aparicio, Ayse Bassez, Ake Borg

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Denise G O'Mahony, Susan J Ramus, Melissa C Southey, Nicola S Meagher, Andreas Hadjisavvas, Ake Borg

Br J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Åke Borg

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study.
Deborah F Nacer, Johan Vallon-Christersson, Nicklas Nordborg, Hans Ehrencrona, Anders Kvist, Åke Borg

Genome Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Mads Thomassen, Romy L S Mesman, Thomas V O Hansen, Mireia Menendez, Maria Rossing, Åke Borg

Hum Mutat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merged testing for colorectal cancer syndromes and re-evaluation of genetic variants improve diagnostic yield: Results from a nationwide prospective cohort.
Sara Svensson, Theofanis Zagoras, Christos Aravidis, Marie Stenmark Askmalm, Erik Björck, Åke Borg

Genes Chromosomes Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Hongyan Li, Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Ake Borg

Genet Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.
Johan Staaf, Jari Häkkinen, Cecilia Hegardt, Lao H Saal, Siker Kimbung, Åke Borg

NPJ Breast Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.
Hani Saghir, Srinivas Veerla, Martin Malmberg, Lisa Rydén, Anna Ehinger, Åke Borg

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmunity to selenoprotein P predicts breast cancer recurrence.
Kamil Demircan, Qian Sun, Ylva Bengtsson, Petra Seemann, Johan Vallon-Christersson, Åke Borg

Redox Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Risks Associated With and Pathogenic Variants.
Shuai Li, Valentina Silvestri, Goska Leslie, Timothy R Rebbeck, Susan L Neuhausen, Åke Borg

J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Ake Borg

Eur J Hum Genet· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Ake Borg

Eur J Hum Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis